These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33234427)

  • 1. A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoise.
    Lawrence RE; Appelbaum PS; Lieberman JA
    Schizophr Res; 2021 Mar; 229():122-131. PubMed ID: 33234427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the ongoing use of placebo in relapse-prevention clinical trials in schizophrenia justified?
    Emsley R; Fleischhacker WW
    Schizophr Res; 2013 Nov; 150(2-3):427-33. PubMed ID: 24094881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.
    Leucht S; Barnes TR; Kissling W; Engel RR; Correll C; Kane JM
    Am J Psychiatry; 2003 Jul; 160(7):1209-22. PubMed ID: 12832232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.
    De Hert M; Sermon J; Geerts P; Vansteelandt K; Peuskens J; Detraux J
    CNS Drugs; 2015 Aug; 29(8):637-58. PubMed ID: 26293744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Placebo-Controlled, Relapse Prevention Trials in Schizophrenia Research Still Necessary or Ethical?
    Lawrence RE; Appelbaum PS; Lieberman JA
    JAMA Psychiatry; 2019 Jul; 76(7):673-674. PubMed ID: 30969331
    [No Abstract]   [Full Text] [Related]  

  • 6. Placebo-controlled trials in schizophrenia: are they ethical? Are they necessary?
    Weijer C
    Schizophr Res; 1999 Feb; 35(3):211-8; discussion 227-36. PubMed ID: 10093865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance treatment with antipsychotic drugs for schizophrenia.
    Leucht S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM
    Cochrane Database Syst Rev; 2012 May; (5):CD008016. PubMed ID: 22592725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse prevention in schizophrenia: evidence from longterm, randomized, double-blind clinical trials.
    Pecenak J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():49-70. PubMed ID: 17262007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial.
    Durgam S; Earley W; Li R; Li D; Lu K; Laszlovszky I; Fleischhacker WW; Nasrallah HA
    Schizophr Res; 2016 Oct; 176(2-3):264-271. PubMed ID: 27427558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-oriented randomisation: A new trial design applied in the Neuroleptic Strategy Study.
    Schulz C; Timm J; Cordes J; Gründer G; Mühlbauer B; Rüther E; Heinze M
    Clin Trials; 2016 Jun; 13(3):251-9. PubMed ID: 27016729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo or active control trials of antipsychotic drugs?
    Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
    Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
    Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
    BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What makes placebo-controlled trials unethical?
    Miller FG; Brody H
    Am J Bioeth; 2002; 2(2):3-9. PubMed ID: 12189059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.
    Emsley R; Chiliza B; Asmal L; du Plessis S; Phahladira L; van Niekerk E; van Rensburg SJ; Harvey BH
    Schizophr Res; 2014 Sep; 158(1-3):230-5. PubMed ID: 24996507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials.
    Schneider-Thoma J; Efthimiou O; Huhn M; Krause M; Reichelt L; Röder H; Davis JM; Salanti G; Leucht S
    Lancet Psychiatry; 2018 Aug; 5(8):653-663. PubMed ID: 30042077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective.
    Laughren TP
    Eur Psychiatry; 2001 Nov; 16(7):418-23. PubMed ID: 11728855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol versus placebo for schizophrenia.
    Joy CB; Adams CE; Lawrie SM
    Cochrane Database Syst Rev; 2001; (2):CD003082. PubMed ID: 11406070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethics in placebo-controlled, acute treatment trials in schizophrenia: Two rival ethical frameworks.
    Lawrence RE; Appelbaum PS
    Schizophr Res; 2024 Feb; 264():372-377. PubMed ID: 38237358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.